| Helping Hands Of North Central Ia | |
|
860 Main St Stanhope IA 50246-7707 | |
| (515) 826-3751 | |
| Not Available |
| Full Name | Helping Hands Of North Central Ia |
|---|---|
| Speciality | Community/behavioral Health |
| Location | 860 Main St, Stanhope, Iowa |
| Authorized Official Name and Position | David Myers (OWNER) |
| Authorized Official Contact | 5158830832 |
| Accepts Medicare Insurance | This clinic does not participate in Medicare Program. |
| Mailing Address | Practice Location Address |
|---|---|
| Helping Hands Of North Central Ia 860 Main St Stanhope IA 50246-7707 Ph: (515) 826-3751 | Helping Hands Of North Central Ia 860 Main St Stanhope IA 50246-7707 Ph: (515) 826-3751 |
| NPI Number | 1962944751 |
|---|---|
| Provider Enumeration Date | 11/09/2016 |
| Last Update Date | 11/09/2016 |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1962944751 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 251S00000X | Community/behavioral Health | (* (Not Available)) | Primary |
News Archive
MicroCHIPS, Inc., a developer of intelligent implant systems, today announced that it has received a 2010 Edison Best New Product Award for its Illume product. The product was awarded Gold in the Science and Medical Category, recognizing the benefit that it will bring to millions of people with diabetes who must manage their blood sugar intensively to stay healthy.
Affymax, Inc. today announced that it has received a $10 million development milestone payment from Takeda Pharmaceutical Company as part of the companies' exclusive global agreement to develop and commercialize peginesatide (formerly known as Hematide™), Affymax's investigational drug for the treatment of anemia in chronic renal failure patients.
A study by researchers from the schools of science and medicine at Indiana University-Purdue University Indianapolis examines the effects of carbon nanoparticles (CNPs) on living cells. This work is among the first to study concentrations of these tiny particles that are low enough to mimic the actual exposure of an ordinary individual.
The Cardiovascular Research Foundation (CRF) will sponsor the Women's Heart Health Summit: "In Pursuit of Excellence: Improving Cardiovascular Outcomes in Women." The goal of the meeting is to examine current prevention, treatment, and key research issues to collectively identify opportunities and recommendations that will lead to improved cardiovascular outcomes in women.
Professor Ron Grunstein, Head of the Sleep and Circadian Research Group and Dr Naomi Rogers, chronobiologist both of the Woolcock Institute of Medical Research, have questioned the ability of doctors in Australia's hospitals to do their job properly given the long hours many are expected to work.
› Verified 6 days ago